Volume 4, Number 3—September 1998
Outbreak of Suspected Clostridium butyricum Botulism in India
To the Editor: Foodborne botulism, particularly associated with Clostridium butyricum, is rare; no cases had been reported in India before this outbreak. A reported case of foodborne botulism represents a public health emergency because of the potential severity of the disease and the possibility of mass exposure to the contaminated product.
In September 1996, the anaerobic section of the All India Institute of Medical Sciences received serum and food samples from the National Institute of Communicable Diseases, Delhi, India, for investigating a possible outbreak of foodborne botulism.
In the early hours of September 18, 1996, 34 of 310 students of a residential school in rural Gujrat complained of abdominal pain, nausea, chest pain, and difficulty in breathing. One of the students, aged 14, died before he could be treated; two others, aged 13, died on their way to the hospital. The remaining 31 students were admitted to a rural hospital; eight were discharged 1 day later after being given symptomatic treatment, while the other 23 were transported by ambulance to an urban emergency department in Ahemdabad, Gujrat. Findings on examination included ptosis, pupillary mydriasis, extraocular palsies, and impairment of conciousness. All students were given symptomatic treatment in the form of stomach lavage and intravenous administration of antibiotics and steroids. Over the subsequent 24 hours, 21 improved clinically and were discharged; however, two (aged 14 and 17 years) had respiratory distress and required mechanical ventilation. Differential diagnosis included botulinum food poisoning, and both patients were administered trivalent (A,B,E) botulinum antitoxin. They responded well to the treatment and were discharged from the hospital 1 month later.
Patients reported that 24 hours before onset of symptoms, they had eaten ladoo (a local sweet), curd, buttermilk, sevu (crisp made of gram flour), and pickle. Food samples were assayed for botulinum toxin and were cultured anaerobically (1). Anaerobic culture of leftover sevu yielded an organism in pure culture whose cultural and biochemical properties were consistent with those of C. butyricum; i.e., it was lipase-negative, fermentative, and did not liquefy gelatin (2). Enrichment cultures of the sevu specimens in enriched chopped meat-glucose-starch medium contained toxin after 5 days of anaerobic incubation at 30°C. This was shown by mouse toxicity test in which the enrichment broth of the specimen was injected intraperitoneally into mice; botulinum toxin was detected by observing its lethal effect on mice. This effect was neutralized by specific polyvalent botulinum antitoxin types A, B, E (Biomed, Warsaw, Poland). Cultures of other food items tested negative for toxigenic organisms. Serum specimens (obtained more than 1 week after the onset of illness) from eight patients with mildly symptomatic illness were negative for toxin.
To test the presence of toxin gene in the isolated strain of C. butyricum, polymerase chain reaction (PCR) was performed. Degenerate primers BoNT 1 and BoNT 2 were used, which amplify a specific 1.1-kb fragment of neurotoxin gene C. botulinum types (A, B, E, F, and G) as well as toxigenic strains of C. baratti and C. butyricum (3). Five Escherichia coli strains containing clones encoding fragments of the C. botulinum neurotoxin genes were used as positive controls in the PCR assay (kindly provided by Alison East, Institute of Food Research, United Kingdom). PCR profile used was as follows: 94°C for 2 min, followed by 25 cycles of 92°C for 1 min, 42°C for 1 min, and 62°C for 5 min, then held at 4°C (Alison East, pers. comm.). An amplified product of 1.1 kb was detected from the culture isolate of sevu.
The outbreak described in this report draws attention to the emergence of new foodborne pathogens and to their association with unusual foods. Human botulism is commonly caused by C. botulinum neurotoxin type A, B, and E (4). In the present study, we showed that a neurotoxigenic C. butyricum was present in the food implicated in a clinically suspected outbreak of botulism in Gujrat, India.
Laboratory studies could not confirm the diagnosis of botulism because clinical materials (such as contents of the gastrointestinal tract, feces) were not submitted for examination for the presence of the botulinum toxin or organisms. It is not surprising that toxin could not be detected in the eight serum samples received by our laboratory. Because of the delay in clinical diagnosis, early serum samples could not be obtained. Toxin is detected in only 13% of serum samples collected more than 2 days after ingestion of botulinum toxin (5). However, the clinical presentation of the patients, response to trivalent botulinum antitoxin, and isolation of toxigenic C. butyricum from one of the consumed food articles strongly suggest that the outbreak was caused by food contaminated with toxigenic C. butyricum.
Neurotoxigenic C. butyricum was first reported in 1986 in two cases of infant botulism in Rome (6). Recently, neurotoxigenic C. butyricum was isolated from the food implicated in an outbreak of clinically diagnosed type E botulism in China (7). In this outbreak, it appears that sevu, because of improper storage, was contaminated with the spores of C. butyricum, which subsequently germinated and produced toxin. To the best of our knowledge, this is the first report of neurotoxigenic C. butyricum causing foodborne botulism in India.
The changing epidemiology of foodborne disease as highlighted in this report calls for improved surveillance, including the development of new technology for identifying outbreaks.
We thank Alison East, Institute of Food Research, Reading Laboratory, United Kingdom, for supplying E. coli clones with BONT gene for PCR; Pradeep Seth, professor and head, Department of Microbiology, All India Institute of Medical Sciences for facilities provided; Biomed Warsaw, Poland, for polyvalent botulinum antitoxin; and the medical and paramedical staff of Civil Hospital, Ahemdabad.
- Hatheway CL. Botulism. In: Balows A, Hausler WJ, Lennette EH, editors. Laboratory diagnosis of infectious diseases: principles and practice. New York: Springer-Verlag: 1988. p. 111-33.
- McCroskey LM, Hatheway CL, Fenicia L, Pasolini B, Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol. 1986;23:201–2.
- Campbell KD, Collins MD, East AK. Gene probes for identification of the Botulinal Neurotoxin gene and specific identification of neurotoxin types B.E. and F. J Clin Microbiol. 1993;31:2255–62.
- Hatheway CL. Clostridium botulinum and other clostridia that produce botulinum neurotoxin. In: Hauschild AHW, Dodds KL, editors. Clostridium botulinum—ecology and control in foods. New York: Marcel Dekker, Inc.; 1992. p. 3-20.
- Woodruff BA, Griffin PM, McCroskey LM, Smart JF, Wainwright RB, Bryant RG, Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988. J Infect Dis. 1992;166:1281–6.
- Aureli PK, Fenicia L, Pasolini B, Gianfranceschi M, McCroskey LM, Hatheway CL. VII. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis. 1986;154:207–11.
- Meng X, Karasawa T, Zou K, Kuang X, Wang X, Lu C, Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism. J Clin Microbiol. 1997;35:2160–2.
Suggested citation: Chaudhry R, Dhawan B, Kumar D, Bhatia R, Gandhi JC, Patel RK, et al. Outbreak of Suspected Clostridium butyricum Botulism in India [letter]. Emerg Infect Dis [serial on the Internet]. 1998, Sep [date cited]. Available from http://wwwnc.cdc.gov/eid/article/4/3/98-0347
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 15, 2010
- Page last updated: December 15, 2010
- Page last reviewed: December 15, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)